Clinical trial
Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans
NCT01977417 is registered in ClinicalTrials.gov with Gary L. Pierce as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans
- Lead sponsor
- Gary L. Pierce
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2012
- Completion date
- April 30, 2021
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obese, prediabetes